Yes, this will be a disaster. Hopefully ASIC will block it, if they have learnt anything from what the small cap public company directors do to their shareholders: max dilution to mates at lowest possible price as often as possible.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
